- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Galderma R&D
Total 1115 results
-
Galderma R&DCompleted
-
Galderma R&DCompletedFacial WrinklesFrance, Germany
-
Galderma R&DCompleted
-
Galderma R&DCompleted
-
Galderma R&DCompletedDry Eye | Blepharitis | MeibomianitisUnited States
-
Galderma R&DCompletedWarts | Actinic Keratosis | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowens DiseaseDenmark, Germany, Norway, Sweden, United Kingdom
-
Galderma R&DCompletedPharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%Acne VulgarisUnited States
-
Galderma R&DCompleted
-
Galderma R&DCompletedHealthy Subjects, Male or Female, of 18-60 Years Old, With Phototype I, II or III, Not Pre-treated/Pre-protected SkinFrance
-
Galderma R&DCompletedErythematous RosaceaUnited States
-
Galderma R&DCompleted
-
Galderma R&DCompletedRosaceaUnited States, Canada
-
Galderma R&DCompletedActinic KeratosisUnited States
-
Galderma R&DCompletedAcneUnited States, Canada, Puerto Rico
-
Galderma R&DCompletedAcne VulgarisUnited States, Canada
-
Galderma R&DCompleted
-
Galderma R&DCompletedPlaque-type PsoriasisUnited States
-
Galderma R&DCompleted
-
Galderma R&DCompletedAcne VulgarisCanada, United States, Germany, Hungary, Puerto Rico
-
Galderma R&DCompletedAcne VulgarisUnited States, Canada
-
Galderma R&DCompleted
-
Galderma R&DCompletedBasal Cell CarcinomaAustralia
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
Galderma R&DCompletedAtopic DermatitisUnited States, Bulgaria
-
Galderma R&DCompletedGene ExpressionUnited States
-
Galderma R&DCompleted
-
Galderma R&DCompleted
-
Galderma R&DCompleted
-
Galderma R&DCompletedWrinkles in DecolletageUnited States
-
Galderma R&DActive, not recruitingChin Retrusion | Chin AugmentationUnited States, Puerto Rico
-
Galderma R&DCompletedNasolabial Folds in Chinese PopulationChina
-
Galderma R&DCompletedSkin WrinklingUnited States
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
Galderma R&DActive, not recruitingPrurigo NodularisUnited States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland, Austria, Denmark, Germany, Hungary, Italy, Sweden, United Kingdom
-
Galderma R&DTerminated
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Galderma R&DCompletedAcne VulgarisUnited States, Canada, France
-
Galderma R&DCompletedSkin WrinklingUnited States
-
Galderma R&DCompletedAcne VulgarisUnited States
-
Galderma R&DCompletedActinic KeratosisUnited States, Germany
-
Galderma R&DCompletedPrurigo NodularisUnited States, Belgium, Canada, France, Korea, Republic of, Netherlands, Poland, Spain, Switzerland
-
Galderma R&DCompletedLateral Canthal LinesUnited States, Canada
-
Galderma R&DCompletedAtopic DermatitisCanada
-
Galderma R&DCompletedAtopic DermatitisUnited States
-
Galderma R&DCompleted
-
Galderma R&DCompleted
-
Galderma R&DCompletedBreast EnhancementSweden, France